Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Polman

Showing results (131-140 of 290) with videos related to

Pageof 29
Sort By:
Neurology|February 1, 1994
Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosisM A van Walderveen, M W Tas, F Barkhof, et al.
Journal of Autoimmunity|June 1, 1993
The significance of in-situ Ia antigen expression in the pathogenesis of autoimmune central nervous system diseaseB M Uitdehaag, C J de Groot, A Kreike, et al.
Journal of Neuroimmunology|August 11, 2001
Active MRI lesion appearance in MS patients is preceded by fluctuations in circulating T-helper 1 and 2 cellsJ Killestein, M H Rep, F Barkhof, et al.
Lancet (London, England)|October 7, 1995
Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosisJ B Crusius, A S Peña, B W Van Oosten, et al.
Clinical Neuropharmacology|June 1, 1993
4-Aminopyridine in patients with multiple sclerosis: dosage and serum level related to efficacy and safetyH A Van Diemen, C H Polman, J C Koetsier, et al.
Journal of Neuroimmunology|September 3, 2004
Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patientsM H J Vogt, S Floris, J Killestein, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 24, 2009
Clinical correlations of brain lesion distribution in multiple sclerosisM M Vellinga, J J G Geurts, E Rostrup, et al.
Acta Neurologica Scandinavica|September 9, 1999
A health-related quality of life questionnaire for multiple sclerosis patientsL E Pfennings, H M Van der Ploeg, L Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2002
Multiple sclerosis functional composite: impact of reference population and interpretation of changesB M J Uitdehaag, H J Adèr, T J A Roosma, et al.
The Journal of Clinical Investigation|May 1, 1997
Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humansM H Rep, B W van Oosten, M T Roos, et al.
Pageof 29

Showing results (131-140 of 290) with videos related to

Sort By:
Pageof 29
Neurology|February 1, 1994
Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosisM A van Walderveen, M W Tas, F Barkhof, et al.
Journal of Autoimmunity|June 1, 1993
The significance of in-situ Ia antigen expression in the pathogenesis of autoimmune central nervous system diseaseB M Uitdehaag, C J de Groot, A Kreike, et al.
Journal of Neuroimmunology|August 11, 2001
Active MRI lesion appearance in MS patients is preceded by fluctuations in circulating T-helper 1 and 2 cellsJ Killestein, M H Rep, F Barkhof, et al.
Lancet (London, England)|October 7, 1995
Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosisJ B Crusius, A S Peña, B W Van Oosten, et al.
Clinical Neuropharmacology|June 1, 1993
4-Aminopyridine in patients with multiple sclerosis: dosage and serum level related to efficacy and safetyH A Van Diemen, C H Polman, J C Koetsier, et al.
Journal of Neuroimmunology|September 3, 2004
Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patientsM H J Vogt, S Floris, J Killestein, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 24, 2009
Clinical correlations of brain lesion distribution in multiple sclerosisM M Vellinga, J J G Geurts, E Rostrup, et al.
Acta Neurologica Scandinavica|September 9, 1999
A health-related quality of life questionnaire for multiple sclerosis patientsL E Pfennings, H M Van der Ploeg, L Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2002
Multiple sclerosis functional composite: impact of reference population and interpretation of changesB M J Uitdehaag, H J Adèr, T J A Roosma, et al.
The Journal of Clinical Investigation|May 1, 1997
Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humansM H Rep, B W van Oosten, M T Roos, et al.
Pageof 29